|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 |
| (11) | Patento numeris | 3408673 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17701686.2 |
| Europos patento paraiškos padavimo data | 2017-01-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/051363 |
| Data | 2017-01-24 |
| (87) | Numeris | WO 2017/129537 |
| Data | 2017-08-03 |
| (30) | Numeris | Data | Šalis |
| 16305065 | 2016-01-25 | EP |
| (72) |
CHIRON-BLONDEL, Marielle, FR
DREYMANN, Jennifer, FR
PACCARD, Caroline, FR
|
| (73) |
Sanofi,
54 Rue de la Boetie, 75008 Paris,
FR
|
| (54) | METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |
| METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER |